481 related articles for article (PubMed ID: 29805703)
1. Current status and future directions of cancer immunotherapy.
Zhang H; Chen J
J Cancer; 2018; 9(10):1773-1781. PubMed ID: 29805703
[TBL] [Abstract][Full Text] [Related]
2. Development of Cancer Immunotherapies.
DeLucia DC; Lee JK
Cancer Treat Res; 2022; 183():1-48. PubMed ID: 35551655
[TBL] [Abstract][Full Text] [Related]
3. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
4. Integrating Bioinformatics Strategies in Cancer Immunotherapy: Current and Future Perspectives.
Washah HN; Salifu EY; Soremekun O; Elrashedy AA; Munsamy G; Olotu FA; Soliman MES
Comb Chem High Throughput Screen; 2020; 23(8):687-698. PubMed ID: 32338212
[TBL] [Abstract][Full Text] [Related]
5. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects.
Chen J; Cong X
Biomed Pharmacother; 2023 Jan; 157():113998. PubMed ID: 36399829
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.
López-Campos F; Gajate P; Romero-Laorden N; Zafra-Martín J; Juan M; Hernando Polo S; Conde Moreno A; Couñago F
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327339
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
8. Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.
Wang Y; Deng W; Li N; Neri S; Sharma A; Jiang W; Lin SH
Front Pharmacol; 2018; 9():185. PubMed ID: 29556198
[TBL] [Abstract][Full Text] [Related]
9. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment.
Yang L; Ning Q; Tang SS
J Immunol Res; 2022; 2022():8052212. PubMed ID: 35340585
[TBL] [Abstract][Full Text] [Related]
11. Emerging Opportunities and Challenges in Cancer Immunotherapy.
Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
[TBL] [Abstract][Full Text] [Related]
12. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.
Hoyos V; Borrello I
Blood; 2016 Sep; 128(13):1679-87. PubMed ID: 27506540
[TBL] [Abstract][Full Text] [Related]
13. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.
Lohmueller J; Finn OJ
Pharmacol Ther; 2017 Oct; 178():31-47. PubMed ID: 28322974
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in anaplastic thyroid cancer.
Ma M; Lin B; Wang M; Liang X; Su L; Okose O; Lv W; Li J
Am J Transl Res; 2020; 12(3):974-988. PubMed ID: 32269728
[TBL] [Abstract][Full Text] [Related]
15. New Approaches for Immune Directed Treatment for Ovarian Cancer.
Hardwick N; Frankel PH; Cristea M
Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Therapies for Pancreatic Ductal Adenocarcinoma.
Sally Á; McGowan R; Finn K; Moran BM
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626020
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Blockade in Breast Cancer Therapy.
Bu X; Yao Y; Li X
Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
[TBL] [Abstract][Full Text] [Related]
19. Cancer Vaccines - SMi's Fourth Annual Conference (September 16-17, 2015 - London, UK).
Searle B
Drugs Today (Barc); 2015 Sep; 51(9):569-73. PubMed ID: 26488036
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
Sanchez K; Page D; McArthur HL
Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
